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ical cardiovascular disease, diabetes, and an estimated riskCardiovascular disease risk status in elderly persons with renal
20% by the Framingham equations, 78% of men and 61%insufficiency.
of women with renal insufficiency had elevated cardiovascularBackground. Renal insufficiency has been independently as-
risk status.sociated with incident cardiovascular disease events in some,
Conclusions. Renal insufficiency is a marker for elevatedbut not all, prospective studies. We determined the prevalence
cardiovascular disease risk in community dwelling elderly adults.of elevated cardiovascular disease risk status among elderly
persons with renal insufficiency.
Methods. This study is a cross-sectional analysis using data
collected at the baseline visit of the Cardiovascular Health Defined by elevated serum creatinine levels, renal in-
Study, which enrolled 5888 community dwelling adults aged
sufficiency has been associated with incident cardiovas-65 years or older from four clinical centers in the United States.
cular disease events and cardiovascular disease mortalityRenal insufficiency was defined as a serum creatinine level
1.3 mg/dL in women and 1.5 mg/dL in men. The outcomes in several [1–5], but not all [6], prospective studies. In
of this study included prevalent cardiovascular disease [prior addition, renal insufficiency is associated with increased
coronary heart disease (CHD) or stroke], subclinical cardiovas- mortality risk in the elderly, in patients surviving myocar-
cular disease (abnormal values of ankle-arm index, carotid
dial infarction, in patients with heart failure, and in pa-ultrasound, and echocardiography) and elevated cardiovascu-
tients who undergo revascularization procedures [7–10].lar risk based upon a diagnosis of diabetes and the Framingham
equations. The association between renal insufficiency and car- Thus, the presence of renal insufficiency may add impor-
diovascular risk status was estimated with and without adjust- tant information in predicting cardiovascular risk, but
ment for other cardiovascular predictors. its role as a potential cardiovascular risk factor, especially
Results. Among the 5808 participants with creatinine levels
in older adults, has not been fully elucidated.measured at entry, 15.9% of men (N  394), and 7.6% of
The utility of renal insufficiency as a marker of cardio-women (N  254) had renal insufficiency. The prevalence of
either clinical or subclinical cardiovascular disease was 64% in vascular disease risk depends upon both the strength of
persons with renal insufficiency compared with 43% in those its association with cardiovascular risk, and the preva-
without it [odds ratio (OR) 2.34; 95% confidence interval (95% lence of renal insufficiency in the population. Because
CI), 1.96, 2.80]. After adjustment for other cardiovascular risk
the incidence and prevalence of renal insufficiency in-factors, renal insufficiency remained significantly associated
crease substantially with advancing age [11, 12], it maywith clinical and subclinical cardiovascular disease (adjusted
OR 1.43; 95% CI, 1.18, 1.75), but the magnitude of association function as an important marker of elevated cardiovascu-
was substantially reduced. After combining clinical and subclin- lar disease risk in the elderly.
The Cardiovascular Health Study (CHS) is a cohort
study of men and women aged greater than 65 years thatKey words: coronary heart disease, stroke, age and cardiovascular dis-
evaluated the prevalence of both subclinical and clinicalease, risk predictors, serum creatinine, subclinical heart disease, kidney
insufficiency, chronic renal disease. cardiovascular disease at entry into the cohort. Non-
invasive measures of subclinical disease included ankle-Received for publication November 20, 2001
arm index, carotid ultrasound, left ventricular mass andand in revised form March 7, 2002
Accepted for publication April 12, 2002 left ventricular ejection fraction. Each of these measure-
ments has been linked to cardiovascular events and mor- 2002 by the International Society of Nephrology
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tality either in the CHS cohort or in other studies. In [15]. For each subject, the baseline echo study was re-
corded using a Toshiba SSH-160A cardiac ultrasoundthis study, we evaluated cross-sectionally the prevalence
of elevated cardiovascular risk among community-dwell- machine (Toshiba America Medical Systems, Inc., Tus-
tin, CA, USA) onto a super-VHS tape and sent to theing elderly persons with renal insufficiency. We hypothe-
sized that an elevated serum creatinine level would be Echocardiography Reading Center for review. Left ven-
tricular mass was calculated with M-mode measurementsa marker of cardiovascular risk.
using the Devereux formula and reported in grams [16].
In addition, left ventricular ejection fraction (LVEF) was
METHODS
categorized semiquantitatively as normal, borderline, or
Subjects and design abnormal.
The CHS is a prospective cohort study of risk factors
Predictor variablesfor cardiovascular disease events in elderly men and
women. Potential participants were randomly sampled The primary predictor variable for this analysis was
the presence of renal insufficiency, based upon serumpeople from Medicare eligibility lists in Forsyth County,
North Carolina; Sacramento County, California; Wash- creatinine levels measured by the Kodak Ektachem 700
Analyser, a colormetric method (Eastman Kodak, Roch-ington County, Maryland; and Pittsburgh, Pennsylvania.
They were invited to participate in CHS if they met ester, NY, USA). In all but 80 of the enrollees, serum
creatinine levels were measured at entry into CHS. In thethe following inclusion criteria: (1) aged 65, (2) not
institutionalized, (3) expected to remain in the current medical literature, various thresholds of serum creatinine
levels have been used to define renal insufficiency. In acommunity for three years or longer, (4) gave informed
consent without requiring a proxy respondent. Among prior study in women, we found that cardiovascular risk
appeared to increase above a serum creatinine level ofthose who met the eligibility requirements and were in-
vited to participate, 57% enrolled in CHS. The initial 1.2 mg/dL [4]. Studies in men have used serum creatinine
cutoffs to define renal insufficiency ranging from 1.4 to5201 participants were enrolled by June 1990; an addi-
tional 687 black participants were recruited and enrolled 1.7 mg/dL [1, 2, 5, 10, 15]. Our current study defined renal
insufficiency as a serum creatinine level 1.5 mg/dL inby June 1993. This study is a cross-sectional analysis
utilizing information obtained upon enrollment into CHS. men, and1.3 mg/dL in women [17]. We also estimated
creatinine clearance levels using the Cockcroft-GaultThe baseline examination included a medical history,
physical examination, laboratory testing, and assessments equation, which we standardized for body surface area
and used to assess trends in cardiovascular disease preva-of cardiovascular disease status. The study design, quality-
control procedures, laboratory methods, and blood-pres- lence with declining renal function [18].
Other predictor variables included demographic vari-sure measurement procedures have been published pre-
viously [13]. ables [age, sex, race (white, black, other), and education
level] and cardiovascular risk factors [history of diabetesAfter five minutes of rest in a supine position, standard
blood pressure cuffs were applied to the right arm and and hypertension, systolic and diastolic blood pressures,
smoking status (never, current, former), low-density lipo-both ankles of the participant by a trained technician.
Each of the three arteries was identified using palpation protein (LDL) and high-density lipoprotein (HDL) cho-
lesterol and triglyceride levels, alcohol intake, body massor a Doppler stethoscope (8 MHz; Huntleigh Technol-
ogy, Inc., PLC, Luton, UK), and the blood pressure was index (BMI), and physical activity (kcals)]. Hypertension
was defined at the baseline examination as either a physi-measured in rapid succession for each artery using a
standard mercury manometer. The ratio of ankle to arm cian’s diagnosis of hypertension, the use of antihyperten-
sive medications, or seated systolic blood pressure levelblood pressure was determined separately for each leg;
participants were classified as having a low ankle-arm 140 and/or diastolic blood pressure level 90 mm Hg.
Diabetes was defined as the use of insulin, oral hypo-index (AAI) if the ratio was0.9 in either leg. The AAI
was determined in all but 143 of CHS participants. glycemic medications, or a fasting glucose level 126
mg/dL.The carotid arteries of participants were evaluated by
high-resolution B-mode ultrasonography to determine
Outcome variablesthe maximal intima-media thickness (IMT) of the com-
mon carotid and internal carotid arteries [14]. The maxi- The outcome for this cross-sectional study was the
presence of elevated cardiovascular risk status at themal IMT was defined for each artery as the mean of the
maximal IMT measures of the near and far walls of both baseline examination of CHS. Elevated cardiovascular
risk was defined to include clinical and subclinical cardio-the left and right sides. This measure was available in
all but 26 CHS participants. vascular disease, diabetes mellitus, and elevated estimated
cardiovascular disease risk based upon the modified Fram-Echocardiography was performed using a standard-
ized protocol that has been described in detail elsewhere ingham equations [19]. Prevalent cardiovascular disease
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Fig. 1. Distribution of serum creatinine levels
among Cardiovascular Health Study (CHS)
participants, stratified by gender (N  5808).
Symbols are: ( ) women; () men.
was defined by a prior history of myocardial infarction, squared tests where appropriate. The prevalence of each
clinical and subclinical cardiovascular outcome was com-angina, bypass surgery, percutaneous transluminal coro-
nary angioplasty, and stroke. pared among participants with and without renal insuffi-
Among participants without prevalent cardiovascular ciency. In addition, we combined categories of outcomes
disease, subclinical cardiovascular disease was defined to determine the prevalence of clinical or subclinical
by abnormal results from the AAI, common carotid cardiovascular disease, diabetes, or estimated cardiovas-
IMT, and echocardiography testing. An AAI 0.9 was cular risk 20% over 10 years. These outcomes were
considered abnormal, as that level has been found to compared between subjects with and without renal insuf-
be a strong predictor of future cardiovascular events ficiency, and across categories of estimated creatinine
[20–22]. We defined an abnormal common carotid IMT clearance.
to be 1.18 mm, corresponding to the highest quintile.
Multivariate analysisIn a prior analysis from CHS, participants with IMT
levels of this magnitude were at greatly elevated risk for Although the primary objective of this study was to
stroke and myocardial infarction [23]. Left ventricular determine whether or not the prevalence of cardiovascu-
hypertrophy (LVH) was defined after standardizing left lar risk is greater in persons with renal insufficiency,
ventricular mass to the participant’s height-squared using multivariate logistic regression also was used to deter-
cutoffs of 100 g/m2 for women and 130 g/m2 for men mine the independent association of renal insufficiency
[24, 25]. Reduced left ventricular ejection fraction with prevalent and subclinical cardiovascular disease.
(LVEF) was defined by combining the borderline and Each of the variables listed above as secondary predictors
abnormal categories [16]. was initially entered into the multivariate model. A back-
Among the participants without clinical or subclinical ward stepwise procedure was then used to sequentially
cardiovascular disease outcomes, the estimated coronary eliminate those variables associated with the outcome at
heart disease risk was determined using the modified P 0.20. We tested for interactions between renal insuffi-
Framingham equations recently incorporated into the ciency and sex, renal insufficiency and diabetes, and renal
Third Report of the National Cholesterol Education Pro- insufficiency and race with the outcomes of clinical and
gram (NCEP) guidelines [19]. Those with diabetes, or an subclinical cardiovascular disease, but found no evidence
estimated risk 20% were considered to have elevated for effect modification (all P values 0.10).
cardiovascular risk.
Statistical analysis RESULTS
The creatinine levels of the 3337 female and 2471Initially, the demographic characteristics and cardio-
vascular risk factors were compared among subjects with male participants in CHS are nearly normally distributed
except for a rightward skew (Fig. 1). The mean valuesand without renal insufficiency, using the t test and chi-
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Table 1. Baseline characteristics of persons with and without renal insufficiency at the 1992–93 baseline examination
Renal insufficiency No renal insufficiency
(N  648) (N  5160)
Characteristics N (%) Mean N (%) Mean P value
Age 76 73 0.0001
Race 0.06
Black 107 (17) 769 (15)
Other 4 (1) 33 (1)
Gender 0.0001
Female 254 (39) 3083 (60)
Education 0.02
Grade 12 226 (35) 1463 (28)
Grade 12, college 213 (33) 1895 (37)
College 205 (32) 1789 (35)
Diabetes 91 (14) 603 (12) 0.08
Hypertension 463 (72) 2935 (57) 0.0001
Mean systolic blood pressure mm Hg 144 139 0.0001
Mean diastolic blood pressure mm Hg 72 71 0.05
LDL cholesterol mg/dL 127 128 0.52
HDL cholesterol mg/dL 49 55 0.0001
Triglycerides mg/dL 154 138 0.0001
Smoking status 0.009
Never 282 (44) 2409 (47)
Former 285 (44) 2136 (41)
Current 81 (13) 609 (12)
Alcohol use drinks/week 2 3 0.02
Physical activity kcals 1274 1774 0.0001
Body mass index kg/m2 27 27 0.61
Table 2. Association of renal insufficiency with prevalent and subclinical cardiovascular disease
Renal insufficiency No renal insufficiency
(N  578) (N  4842) Unadjusted Adjusteda
N (%) OR 95% CI OR 95% CI
Prevalent clinical disease
Myocardial infarction 106 (18) 409 (8) 2.43 1.93, 3.08 1.55 1.19, 2.01
Angina 144 (25) 718 (15) 1.91 1.55, 2.34 1.24 0.99, 1.56
Stroke 50 (9) 155 (3) 2.86 2.06, 3.99 2.18 1.53, 3.11
Subclinical disease
(persons without clinical CV disease)
Ankle-arm index 0.9 69 (12) 352 (7) 2.29 1.73, 3.05 1.40 1.02, 1.92
Common carotid IMT 100 (17) 618 (13) 1.95 1.53, 2.49 1.12 0.85, 1.48
Left ventricular hypertrophy 16 (3) 174 (4) 0.96 0.57, 1.62 1.11 0.65, 1.89
Left ventricular ejection fraction
(borderline or abnormal) 34 (6) 204 (4) 1.82 1.25, 2.66 1.31 0.88, 1.95
Prevalent cardiovascular disease 208 (36) 968 (20) 2.25 1.87, 2.70 1.47 1.20, 1.80
Subclinical diseaseb 161 (44) 1123 (29) 1.91 1.54, 2.38 1.22 0.95, 1.55
Any prevalent clinical or subclinical disease 369 (64) 2080 (43) 2.34 1.96, 2.80 1.43 1.18, 1.75
a Adjusted for characteristics listed in Table 1
b Denominator is persons without prevalent cardiovascular disease
were 0.9  0.3 mg/dL for women and 1.2  0.4 mg/dL mean diastolic blood pressure levels were only 1 mm Hg
higher (P  0.05). High-density lipoprotein (HDL) cho-for men. The proportions with renal insufficiency, as
defined in this study, were 7.6% of women (N  254) lesterol levels were 4 mg/dL lower on average among both
men (44 vs. 48 mg/dL; P  0.0001) and women (55 vs. 59and 15.9% of men (N  394).
mg/dL; P 0.0001) with renal insufficiency, and triglycer-
Characteristics of participants with and without ide levels were higher.
renal insufficiency
Renal insufficiency and cardiovascular diseaseThe participants with renal insufficiency were three
years older on average, but had similar racial composition In the unadjusted analysis, the prevalence of myocar-
dial infarction or stroke history was more than doubleto those without renal insufficiency (Table 1). Mean sys-
tolic blood pressure levels were 5 mm Hg higher for par- in participants with renal insufficiency (Table 2). Over
one-third of participants with renal insufficiency had priorticipants with renal insufficiency (P  0.0001), whereas
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myocardial infarction, angina, bypass surgery, or stroke,
compared with only one-fifth of participants without re-
nal insufficiency (P 0.0001). After multivariate adjust-
ment for differences in baseline characteristics, renal
insufficiency was associated with a nearly 50% increased
odds for the prevalence of clinical cardiovascular disease.
Among CHS subjects without prevalent clinical car-
diovascular disease, those with renal insufficiency had
90% greater odds of having subclinical cardiovascular
disease (Table 2). Abnormal AAI, LVEF, and carotid
IMT levels were significantly more common in persons
with renal insufficiency, whereas the prevalence of LVH
was similar in the two groups. Adjusting for other charac-
teristics of the participants substantially reduced the as-
sociation with these subclinical disease measures, but
renal insufficiency remained an independent predictor
of reduced AAI.
Fig. 2. Disease prevalence by estimated creatinine clearance. (N 145Overall, participants with renal insufficiency had a
for ‘30’; 423 for ‘30-39’; 1051 for ‘40-49’; 1426 for ‘50-59’; 1354 for
50% higher prevalence of clinical and subclinical cardio- ‘60-69’; 769 for ‘70-79’; and 622 for ‘80’ mL/min/1.73 m2). Clinical
disease () includes CHD and stroke; subclinical disease ( ) includesvascular disease. This association remained statistically
ankle-arm index 0.9, common carotid IMT in upper quintile, leftsignificant after multivariate adjustment (OR 1.43; 95%
ventricular hypertrophy, and abnormal/borderline left ventricular ejec-
CI, 1.18, 1.75). tion fraction. P value for linear trend 0.001 for both clinical and
subclinical disease.
Renal insufficiency as a marker for cardiovascular risk
Among the 578 CHS participants with renal insuffi-
ciency who had no missing data, we evaluated the pro-
cular disease increased from under 40% among thoseportion at elevated cardiovascular risk. The prevalence
with estimated creatinine clearance levels 60 mL/min/of either clinical or subclinical cardiovascular disease
1.73 m2, to 48% for those 40 to 59 mL/min/1.73 m2, andwas 64% (95% CI, 60%, 68%). Of the remaining 209
over 68% for participants 40 mL/min/1.73 m2 (P valueparticipants with renal insufficiency, 46 had either diabe-
for trend 0.001).tes or a Framingham 10-year estimated risk20%. Over
72% of the participants with renal insufficiency met one Comparison with traditional cardiovascular risk factors
of these definitions for elevated cardiovascular risk com-
We compared the association of renal insufficiencypared with 50% of persons without renal insufficiency
and cardiovascular risk status in the elderly with tradi-(P  0.0001 for difference); among CHS participants
tional risk factors: high LDL levels, low HDL levels,without prevalent cardiovascular disease, 56% of those
current tobacco use, hypertension and diabetes (Tablewith renal insufficiency were at elevated cardiovascular
3). The adjusted association of renal insufficiency withrisk compared with 39% of those without renal insuffi-
prevalent cardiovascular disease was similar to that ofciency (P  0.0001). Based on the definitions used in
hypertension, stronger than current smoking and highthis study, the prevalence of elevated cardiovascular risk
LDL, but not as strong as low HDL and diabetes in thiswas greater in men with renal insufficiency (78%; 95%
cohort. The adjusted association of renal insufficiencyCI, 73%, 82%) than in women (61%; 95% CI, 55%,
with either prevalent or subclinical cardiovascular dis-68%; P  0.001 for comparison of proportions).
ease appeared comparable to low HDL and hypertension,
Estimated creatinine clearance and but was less strong than diabetes or current smoking.
cardiovascular disease
To determine the association of cardiovascular disease
DISCUSSIONprevalence with various levels of renal function, esti-
We found renal insufficiency to be a marker for ele-mated creatinine clearance levels were used (Fig. 2).
vated cardiovascular disease risk in community dwellingThe prevalence of clinical cardiovascular disease was
elderly adults. Defined as prevalent cardiovascular dis-less than 20% for participants with estimated creatinine
ease, abnormal subclinical cardiovascular disease mea-clearance levels 60 mL/min/1.73 m2, 25% for those 40
surements, diabetes, or elevated Framingham risk20%to 59 mL/min/1.73 m2, and greater than 30% for those
over 10 years, nearly three-fourths of participants withless than 40 mL/min/1.73 m2 (P 0.001 for linear trend).
The prevalence of either clinical or subclinical cardiovas- increased creatinine levels were at high risk. Even among
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Table 3. A comparison of renal insufficiency with traditional cardiovascular risk factors for predicting prevalent
and subclinical cardiovascular disease in the elderlya
Any prevalent or
Prevalent CVD Subclinical CVD subclinical CVD
OR (95% CI)
Renal insufficiency
Unadjusted 2.25 (1.87, 2.70) 1.91 (1.54, 2.38) 2.34 (1.96, 2.80)
Adjustedb 1.47 (1.20, 1.80) 1.22 (0.95, 1.55) 1.43 (1.18, 1.75)
LDL 130 mg/dL
Unadjusted 0.97 (0.85, 1.11) 1.17 (1.02, 1.33) 1.09 (0.98, 1.22)
Adjusted 1.06 (0.92, 1.21) 1.35 (1.17, 1.57) 1.25 (1.11, 1.41)
HDL 40 mg/dL
Unadjusted 2.27 (1.94, 2.66) 1.44 (1.20, 1.73) 1.95 (1.68, 2.25)
Adjusted 1.67 (1.39, 2.02) 1.30 (1.05, 1.60) 1.47 (1.23, 1.76)
Smoking current
Unadjusted 0.84 (0.68, 1.03) 1.75 (1.45, 2.12) 1.39 (1.17, 1.64)
Adjusted 0.88 (0.70, 1.10) 2.28 (1.85, 2.82) 1.75 (1.46, 2.10)
Hypertension
Unadjusted 1.49 (1.30, 1.71) 1.96 (1.71, 2.25) 1.89 (1.69, 2.11)
Adjusted 1.46 (1.26, 1.69) 1.42 (1.20, 1.68) 1.49 (1.30, 1.70)
Diabetes
Unadjusted 1.91 (1.59, 2.29) 2.06 (1.67, 2.53) 2.25 (1.90, 2.68)
Adjusted 1.60 (1.31, 1.96) 1.78 (1.41, 2.23) 1.90 (1.57, 2.30)
a Referent group for prevalent CVD is individuals without prevalent CVD; referent group for all others is individuals without prevalent or subclinical CVD
b Adjusted for all Table 1 characteristics and risk factors including those listed in this Table
those with no clinical history of cardiovascular disease, measures are poorly achieved in this patient population.
One study found only one-third of persons with renalover half of participants with renal insufficiency had sub-
stantial cardiovascular risk. insufficiency in the United States using antihypertensive
agents to have blood pressure control below the generalIn prior epidemiologic studies, renal insufficiency has
been associated independently with cardiovascular dis- population goal of 140/90, and only 14% to have reached
the target of 130/85 for persons with target organ damageease incidence and mortality [2–5]. As with any potential
risk factor, the importance of renal insufficiency depends [12]. A Canadian survey of the medical treatment for
persons with renal insufficiency and cardiovascular dis-upon both its strength of association with cardiovascular
disease and its prevalence. Based on our definition of ease found only 27% to be on aspirin therapy and only
18% to be taking statins [28]. We have previously foundelevated creatinine levels, renal insufficiency was present
in 11% of community dwelling elderly adults. Among that persons with renal insufficiency and established
CHD are less likely to receive aspirin despite their in-older adults not known to have prevalent cardiovascular
disease, renal insufficiency may be a particularly useful creased mortality risk [4, 8].
The primary limitation of this study is the cross-sec-marker for elevated cardiovascular disease risk. Elderly
persons with renal insufficiency thus may not need so- tional design, as we could not determine whether the
renal disease preceded the cardiovascular risk. An addi-phisticated screening tools to determine their high-risk
status. Unlike other novel cardiovascular risk predictors tional issue is that we were limited to those diagnostic
tests that were included in CHS. We also may havethat require difficult assays or expensive diagnostic tests,
persons with renal insufficiency can be easily identified underestimated the prevalence of elevated cardiovascu-
lar risk because conservative thresholds were used forwith a simple blood test routinely measured in nearly
every healthcare setting. the subclinical cardiovascular disease measures. For ex-
ample, we considered only the highest quintile of carotidThese results have important implications for cardio-
vascular disease prevention in persons with renal insuffi- IMT to be abnormal, although the third and fourth
quintiles are also associated with substantial increasesciency. The 6th Joint National Committee on Hyperten-
sion recommended lower blood pressure treatment targets in cardiovascular risk [23]. Furthermore, the Framing-
ham risk equations used in this study may not be as wellin all persons with chronic renal disease, regardless of
their cardiovascular disease status [26]. The National validated in elderly and non-white participants.
Serum creatinine levels were used to define renal in-Kidney Foundations’ Task Force on Cardiovascular Pre-
vention has recommended that the treatment target for sufficiency because virtually all studies associating renal
insufficiency and cardiovascular outcomes have beenLDL levels be 100 mg/dL in all persons with chronic
kidney disease [27]. However, these blood pressure and based upon serum creatinine measurements and not on
other determinants of renal function, such as glomerularlipid level goals and other cardiovascular prevention
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